Application and Validation of a New Histologic Staging and Grading System for Primary Biliary Cirrhosis
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We proposed a new grading and staging system for primary biliary cirrhosis (PBC), which takes into account the degree of both chronic cholangitis activity (CA) and hepatitic activity (HA) for grading disease activity and that of fibrosis, bile duct loss, and chronic cholestasis for staging. In this study, we validated our new system. METHODS: Using liver biopsy specimens from 166 cases of PBC, chronic cholangitis with mild periductal lymphoplasmacytic infiltration, including chronic nonsuppurative destructive cholangitis, and the combined activity of interface hepatitis and lobular hepatitis were categorized into 4 grades on the basis of their degree and distribution (CA0-3 and HA0-3, respectively). For staging, because orcein staining was not available in this study, 2 criteria (fibrosis and bile duct loss) were independently scored from 0 to 3 on the basis of their degrees, and a final stage score was created from the sum. RESULTS: Although there was a relatively uniform distribution of CA0/1/2/3 cases, the cases of HA0/1/2/3 were distributed as 21%, 64%, 13%, and 3%, respectively, with a prominent number of cases categorized as having none or mild HA. The distribution of stages 1 to 4 using our system was considerably different from that using the classic system and, importantly, showed a correlation with patient outcome. CONCLUSIONS: Our system revealed that the activities of chronic cholangitis and hepatitis did not correlate with each other in terms of degree and that our staging system properly reflected the outcome of PBC patients. The present study could validate the effectiveness of this new system for characterizing the pathologic condition of PBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A new staging system for PBC was recently proposed, based on the assessment of chronic cholangitis and hepatitis activity [58][59][60].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [59]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This approach identifies four different stages by attributing a score of 0-3 to three histologic components: fibrosis, bile duct loss and deposition of orcein-positive granules.”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A total score of 0 identifies stage 1 (no or minimal progression), 1-3 identifies stage 2 (mild progression), 4-6 identifies stage 3 (moderate progression), and 7-9 identifies stage 4 (advanced progression).”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029 · cited 1×
“In the majority of chronic liver diseases such as chronic viral hepatitis, the degree of fibrosis constitutes the basis for staging.(5,20,21) However, because cholestasis, in addition to fibrosis, is also a major causative factor of liver failure in PBC,(3,4,22,23) liver transplantation cases of non-cirrhotic livers (…”
BackgroundNonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · cited 1×
“In the majority of chronic liver diseases such as chronic viral hepatitis, the degree of fibrosis constitutes the basis for staging.(5,20,21) However, because cholestasis, in addition to fibrosis, is also a major causative factor of liver failure in PBC,(3,4,22,23) liver transplantation cases of non-cirrhotic livers (…”
BackgroundClassification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593 · cited 1×
“In the majority of chronic liver diseases such as chronic viral hepatitis, the degree of fibrosis constitutes the basis for staging.(5,20,21) However, because cholestasis, in addition to fibrosis, is also a major causative factor of liver failure in PBC,(3,4,22,23) liver transplantation cases of non-cirrhotic livers (…”
BackgroundKaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753 · cited 1×
“,(6) Scheuer,(7,8) Popper and Schaffner,(9) and Ludwig et al.(10) have been used since the 1960’s.”
MethodSymposium: Advances in Liver Pathology [Abridged]: Primary Biliary Cirrhosis
Scheuer, P. J. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706001205 · Cited by 557
Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
(1959) · Postgraduate Medical Journal · doi:10.1136/pgmj.45.522.305-d · Cited by 497
Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 455
PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.
Rubin, E., Schaffner, F., & Pópper, H. (1965) · PubMed Central · Cited by 374
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Lleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Current understanding of primary biliary cholangitis
Tanaka, A. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0028 · Cited by 158
“Overall survival was stratified better with Nakanuma’s classification than with the classic system.(82) TREATMENT”
MethodYou, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International · doi:10.1007/s12072-021-10276-6 · Cited by 133
“The novel criteria for histology could stratify the risk for PBC progression and outcomes [93, 94].”
BackgroundAutoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
Sarcognato, S., Sacchi, D., Grillo, F., Cazzagon, N., Fabris, L., Cadamuro, M., Cataldo, I., Covelli, C., Mangia, A., & Guido, M. (2021) · Pathologica · doi:10.32074/1591-951x-245 · Cited by 140
Metadata
- Authors
- Harada, K., Hsu, M., Ikeda, H., Zeniya, M., & Nakanuma, Y.
- Affiliations
- Kanazawa University (JP)
- Kanazawa University Hospital (JP)
- Jikei University School of Medicine (JP)
- Corresponding author
- Harada, Kenichi
- Hsu, Maylee
- Nakanuma, Yasuni
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2013-02
- Volume
- 47
- Issue
- 2
- Pages
- 174-181
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2036439745
- Semantic Scholar
- 52034f59212a2f355eaf036649aa16c18cee1f2a
- Cited by
- 46
- References
- 26
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 1 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 3 · 2014: 5
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) (submittedVersion, cc-by-nc-nd)
- Funders
- Medical Center, University of Pittsburgh
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- primary biliary cirrhosis, histologic staging, histologic grading, interface hepatitis, liver fibrosis, bile duct loss, disease activity, patient outcomes
- MeSH terms
- Bile Ducts, Biopsy, Cholangitis, Female, Humans, Liver, Liver Cirrhosis, Biliary, Male, Middle Aged, Predictive Value of Tests, Prognosis, Severity of Illness Index, Time Factors, Reproducibility of Results, Disease Progression, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Application and Validation of a New Histologic Staging and Grading System for Primary Biliary Cirrhosis. https://app.cochat.ai/papers/10.1097/mcg.0b013e31827234e4
- The paper
- Harada, K., Hsu, M., Ikeda, H., Zeniya, M., & Nakanuma, Y. (2013). Application and Validation of a New Histologic Staging and Grading System for Primary Biliary Cirrhosis. Journal of Clinical Gastroenterology. https://doi.org/10.1097/mcg.0b013e31827234e4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.